Petros Pharmaceuticals Inc (PTPI)
0.4155
-0.05
(-10.47%)
USD |
NASDAQ |
Jun 14, 16:00
0.4155
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Accounts Payable (Quarterly): 2.137M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.137M |
December 31, 2023 | 1.713M |
September 30, 2023 | 1.355M |
June 30, 2023 | 1.784M |
March 31, 2023 | 1.858M |
December 31, 2022 | 1.806M |
September 30, 2022 | 2.084M |
Date | Value |
---|---|
June 30, 2022 | 1.904M |
March 31, 2022 | 3.700M |
December 31, 2021 | 4.558M |
September 30, 2021 | 5.312M |
June 30, 2021 | 2.598M |
March 31, 2021 | 5.276M |
December 31, 2020 | 5.610M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.355M
Minimum
Sep 2023
5.610M
Maximum
Dec 2020
2.978M
Average
2.111M
Median
Accounts Payable (Quarterly) Benchmarks
Avalo Therapeutics Inc | 0.916M |
Imunon Inc | 2.358M |
iBio Inc | 1.228M |
Ocugen Inc | 1.731M |
Gritstone Bio Inc | 7.248M |